Physician profile
Harish Thaker
NPI 1912971086
$1,959.56
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,699 · 2020: $192 · 2021: $68.77.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $278.22 | 2019-2020 | |
| Amgen INC. | $257.82 | 2019-2021 | |
| Portola Pharmaceuticals, LLC | $226.27 | 2019 | |
| Genzyme Corporation | $200.21 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2019 | |
| Pfizer INC. | $124.99 | 2019 | |
| Emd Serono, INC. | $110.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $71.79 | 2019 | |
| Livanova USA, INC. | $71.79 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $68.29 | 2019 | |
| Eisai INC. | $65.42 | 2019 | |
| Tanabe Pharma America, INC. | $47.08 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $45.04 | 2019 | |
| Avanir Pharmaceuticals, INC. | $38.50 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.26 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $30.86 | 2019 | |
| Biogen, INC. | $24.61 | 2019 | |
| Akcea Therapeutics, INC. | $20.29 | 2020 | |
| Sk Life Science, INC. | $19.14 | 2020 | |
| Allergan, INC. | $18.38 | 2020 | |
| Acorda Therapeutics, INC | $18.05 | 2020 | |
| Acadia Pharmaceuticals INC | $17.20 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.50 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.37 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harish Thaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.